insights_auto
Why is KNSA up 6,25%?
Dive Deeperchevron_right
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
US$93,86
arrow_upward
+6,25%(+5,52) 1D
US$95,00
arrow_upward
+1,21% (+1,14)bedtimeAfter hours
Closed: 6 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
US$88,92
High
US$94,48
Low
US$88,41
Mkt. cap
7,37 ຕື້
Avg. vol.
830,89 ພັນ
Volume
636,35 ພັນ
P/E ratio
71,64
52-wk high
US$98,48
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
Open
US$88,92
High
US$94,48
Low
US$88,41
Mkt. cap
7,37 ຕື້
Avg. vol.
830,89 ພັນ
Volume
636,35 ພັນ
P/E ratio
71,64
52-wk high
US$98,48
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
News stories
From web sources and news partners
Seeking Alpha
·
1 ຊົ່ວໂມງກ່ອນ
The Nasdaq Is Toast: QQQ Could Go 40% Lower. Here's How, And What Could Stop It. (QQQ)
Yahoo Finance
·
1 ມື້ກ່ອນ
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg.com
·
1 ມື້ກ່ອນ
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersລອນດອນ, ປະເທດອັງກິດ, ສະຫະລາດຊະອະນາຈັກ
SectorHealth Care
IndustryBiotechnology
Websitekiniksa.com